Cargando…

Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen

AIM: To investigate the enhancement of humoral immunity when CpG ODN (cytidine phosphate guanosine oligodeoxynucleotides) and aluminium adjuvants are complexed with the HCV (Hepatitis C virus) recombinant immunogen in mice. METHODS: After immunizing Balb/c mice with the recombination HCV antigen adj...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Na, Xiu, Bing S, Wang, Guo H, Chen, Kun, Bai, Guan Z, Song, Xiao G, Zhu, Cui X, Dai, Zhen H, Yang, Xi Q, Zhang, He Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261835/
https://www.ncbi.nlm.nih.gov/pubmed/22054420
http://dx.doi.org/10.1186/1743-422X-8-507
_version_ 1782221637129601024
author Zhan, Na
Xiu, Bing S
Wang, Guo H
Chen, Kun
Bai, Guan Z
Song, Xiao G
Zhu, Cui X
Dai, Zhen H
Yang, Xi Q
Zhang, He Q
author_facet Zhan, Na
Xiu, Bing S
Wang, Guo H
Chen, Kun
Bai, Guan Z
Song, Xiao G
Zhu, Cui X
Dai, Zhen H
Yang, Xi Q
Zhang, He Q
author_sort Zhan, Na
collection PubMed
description AIM: To investigate the enhancement of humoral immunity when CpG ODN (cytidine phosphate guanosine oligodeoxynucleotides) and aluminium adjuvants are complexed with the HCV (Hepatitis C virus) recombinant immunogen in mice. METHODS: After immunizing Balb/c mice with the recombination HCV antigen adjuvanted with pUCpGs10 and/or aluminium(antigen+CpG+alum, antigen+CpG, antigen+alum, antigen+PBS), enzyme-linked immunosorbent assay (ELISA) was used to measure the specific serum antibody titers of IgG, to determine the neutralization response to various peptide genotypes, and to determine the concentration of IL-6 and IL-10 in supernatants of in vitro cultured splenic lymphocytes. Enzyme-linked immunospot assay (ELISPOT) was used to quantify the non-specific and specific splenic antibody-secreting cells (ASCs), and flow cytometry (FCM) determined the ratio of different splenic lymphocytes. The serum of rabbits immunized with the recombinant pBVGST/HVR1 antigen immunoprecipitated the HCV isolated from 12 patients' serum. RESULTS: The sera antibody titers were 1:51200, 1:9051, 1:18102, 1:6400 respectively after the final immunization and demonstrated good neutralization responses to the six gene peptide containing 1a, 1b, 2a, 3a, 4a and 6a. The aluminum adjuvant increased the population of both specific ASCs (P < 0.01) and total ASCs(P < 0.05), with a proportional rise in concentrations of CD19(+)CD27(+ )(P < 0.05), as well as levels of IL-6, IL-10 (P < 0.05) in splenic lymphocytes. The results clearly indicated a significantly higher number of CD19(+)CD38(+ )splenic lymphocytes with the aluminum and pUCpGs10 adjuvant present compared to the control group(P < 0.05). Anti-HVR1 antibody in induced mice can cross-reactively capture HCV particles (10/12). CONCLUSIONS: 1. The aluminum adjuvant induces a potent Th2-biased immune response by increasing both the populations of specific and total ASCs and the ratio of CD19(+)CD27(+ )cells. 2. The pUCpGs10 complexed with the aluminum adjuvant boosts the population of plasma cells and increase the efficiency of the immune response. 3. The two adjuvants have synergistic effects on humoral immunity. 4. The recombinant HVR1 protein has the possibility of generating broadly reactive anti-HVR1 antibody.
format Online
Article
Text
id pubmed-3261835
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32618352012-01-20 Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen Zhan, Na Xiu, Bing S Wang, Guo H Chen, Kun Bai, Guan Z Song, Xiao G Zhu, Cui X Dai, Zhen H Yang, Xi Q Zhang, He Q Virol J Research AIM: To investigate the enhancement of humoral immunity when CpG ODN (cytidine phosphate guanosine oligodeoxynucleotides) and aluminium adjuvants are complexed with the HCV (Hepatitis C virus) recombinant immunogen in mice. METHODS: After immunizing Balb/c mice with the recombination HCV antigen adjuvanted with pUCpGs10 and/or aluminium(antigen+CpG+alum, antigen+CpG, antigen+alum, antigen+PBS), enzyme-linked immunosorbent assay (ELISA) was used to measure the specific serum antibody titers of IgG, to determine the neutralization response to various peptide genotypes, and to determine the concentration of IL-6 and IL-10 in supernatants of in vitro cultured splenic lymphocytes. Enzyme-linked immunospot assay (ELISPOT) was used to quantify the non-specific and specific splenic antibody-secreting cells (ASCs), and flow cytometry (FCM) determined the ratio of different splenic lymphocytes. The serum of rabbits immunized with the recombinant pBVGST/HVR1 antigen immunoprecipitated the HCV isolated from 12 patients' serum. RESULTS: The sera antibody titers were 1:51200, 1:9051, 1:18102, 1:6400 respectively after the final immunization and demonstrated good neutralization responses to the six gene peptide containing 1a, 1b, 2a, 3a, 4a and 6a. The aluminum adjuvant increased the population of both specific ASCs (P < 0.01) and total ASCs(P < 0.05), with a proportional rise in concentrations of CD19(+)CD27(+ )(P < 0.05), as well as levels of IL-6, IL-10 (P < 0.05) in splenic lymphocytes. The results clearly indicated a significantly higher number of CD19(+)CD38(+ )splenic lymphocytes with the aluminum and pUCpGs10 adjuvant present compared to the control group(P < 0.05). Anti-HVR1 antibody in induced mice can cross-reactively capture HCV particles (10/12). CONCLUSIONS: 1. The aluminum adjuvant induces a potent Th2-biased immune response by increasing both the populations of specific and total ASCs and the ratio of CD19(+)CD27(+ )cells. 2. The pUCpGs10 complexed with the aluminum adjuvant boosts the population of plasma cells and increase the efficiency of the immune response. 3. The two adjuvants have synergistic effects on humoral immunity. 4. The recombinant HVR1 protein has the possibility of generating broadly reactive anti-HVR1 antibody. BioMed Central 2011-11-04 /pmc/articles/PMC3261835/ /pubmed/22054420 http://dx.doi.org/10.1186/1743-422X-8-507 Text en Copyright ©2011 Zhan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhan, Na
Xiu, Bing S
Wang, Guo H
Chen, Kun
Bai, Guan Z
Song, Xiao G
Zhu, Cui X
Dai, Zhen H
Yang, Xi Q
Zhang, He Q
Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen
title Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen
title_full Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen
title_fullStr Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen
title_full_unstemmed Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen
title_short Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen
title_sort enhancement of humoral immunity in mice by coupling pucpgs10 and aluminium to the hcv recombinant immunogen
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261835/
https://www.ncbi.nlm.nih.gov/pubmed/22054420
http://dx.doi.org/10.1186/1743-422X-8-507
work_keys_str_mv AT zhanna enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT xiubings enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT wangguoh enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT chenkun enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT baiguanz enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT songxiaog enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT zhucuix enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT daizhenh enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT yangxiq enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen
AT zhangheq enhancementofhumoralimmunityinmicebycouplingpucpgs10andaluminiumtothehcvrecombinantimmunogen